https://www.marketscreener.com/quote/stock/SUPERNUS-PHARMACEUTICALS--10523839/news/Supernus-Pharmaceuticals-Inc-Resubmits-NDA-for-SPN-830-Apomorphine-Infusion-Device-45034314/?utm_source=telegram&utm_medium=social&utm_campaign=share